News & Updates
Filter by Specialty:

COVID-19 variants carry no increased autoimmune sequelae risk
COVID-19 variants delta and omicron BA.1 or BA.2 do not pose a substantial threat of long-term autoimmune complications, except for a modest elevation in inflammatory bowel disease and bullous skin disorders among hospitalized patients during the omicron predominance in Singapore, as shown in a study.
COVID-19 variants carry no increased autoimmune sequelae risk
16 Sep 2024
Fewer CV events after COVID-19 vaccine-related myocarditis
In a nationwide French cohort study, myocarditis attributed to COVID-19 mRNA vaccination causes fewer cardiovascular (CV) events at 18 months of follow-up than that attributed to SARS-CoV-2 infection or myocarditis of conventional aetiologies.
Fewer CV events after COVID-19 vaccine-related myocarditis
13 Sep 2024
PVR predicts death in patients with bronchiectasis-associated pulmonary hypertension
Pulmonary vascular resistance (PVR) may be used to distinguish severe (PVR >4 Wood Units) from nonsevere pulmonary hypertension (PVR ≤4 Wood Units) among patients with bronchiectasis-associated pulmonary hypertension (BAPH) and identify those who are at higher risk of mortality, a study suggests.
PVR predicts death in patients with bronchiectasis-associated pulmonary hypertension
04 Sep 2024
Steroid use may increase mortality in acute exacerbation of FILD
A high mortality risk hounds patients with acute exacerbation (AE) of fibrotic interstitial lung disease (FILD) despite treatment with corticosteroids, reports a study, noting that such risk is similar to that seen in those with AE of idiopathic pulmonary fibrosis (IPF).